Smart Tissue Autonomous Robot (STAR) Market Forecast Highlights Expansion From $0.36 Billion To $0.77 Billion Through 2030
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Smart Tissue Autonomous Robot (STAR) Market Value Expansion And Long-Term Growth Outlook
The size of the smart tissue autonomous robot (star) market has seen an exponential increase lately. This market is projected to expand from $0.3 billion in 2025 to $0.36 billion in 2026, achieving a compound annual growth rate (CAGR) of 20.3%. In the past, the market’s expansion was propelled by several factors, including the proliferation of robotic surgery platforms, a heightened demand for minimally invasive procedures, improvements in surgical imaging, investments made by hospitals in robotics, and the rising need for precision in surgical operations.
The smart tissue autonomous robot (star) market is anticipated to experience significant expansion in the coming years. Projections indicate it will reach $0.77 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 20.5%. This growth during the forecast period is fueled by factors such as expanded research in autonomous surgery, the integration of AI into surgical workflows, the increasing demand for advanced sensing instruments, a strong emphasis on reproducible surgical outcomes, and investment in next-generation surgical robotics. Key trends for this period encompass autonomous soft tissue suturing systems, AI-guided engines for surgical decisions, robotics capable of real-time tissue tracking, surgical instruments providing force feedback, and image-driven robotic navigation.
Download A Free Sample Report For Comprehensive Market Insights:
Smart Tissue Autonomous Robot (STAR) Market Expansion Drivers: What Is Shaping Future Growth?
The increasing need for minimally invasive surgical procedures is projected to drive the expansion of the smart tissue autonomous robot (STAR) market in the future. These procedures involve operations conducted via small cuts or natural orifices, employing specialized tools to lessen tissue damage, blood loss, and recovery periods, all while preserving surgical accuracy. A primary factor behind this growing demand is improved patient safety. The smart tissue autonomous robot (STAR) addresses this demand by accurately performing intricate soft-tissue tasks through tiny incisions, thereby decreasing human mistakes, lessening tissue harm, and boosting overall surgical precision and patient healing. For example, in June 2024, the American Society of Plastic Surgeons, a US-based non-profit organization, reported that minimally invasive hyaluronic acid filler procedures reached 5.29 million in 2023, marking an 8% increase compared to 2022. Consequently, the expanding need for minimally invasive surgical procedures is fueling the growth of the smart tissue autonomous robot (STAR) market. Growing hospital investments in robotic infrastructure are anticipated to boost the smart tissue autonomous robot (STAR) market’s growth moving forward. This infrastructure encompasses robotic systems, along with the necessary software, hardware, and facilities for the effective installation, operation, and upkeep of robotic technologies within an institution. The impetus behind increasing hospital spending on robotic infrastructure is the requirement for enhanced surgical precision. The smart tissue autonomous robot (STAR) facilitates these rising investments by providing a sophisticated autonomous surgical platform that combines artificial intelligence, imaging, and precise robotics, thereby allowing hospitals to elevate their surgical capacities, achieve better clinical results, and optimize the return on their robotic technology investments. For example, in Nov 2025, Springer Nature, a Germany-based academic and scientific publishing company, indicated that surgical robot ownership among trusts saw a 42% increase, rising from 36 to 51, with its application broadening to 49 trusts for general surgery and doubling from 13 to 26 trusts for emergency procedures. Consequently, the increasing hospital investments in robotic infrastructure are propelling the smart tissue autonomous robot (STAR) market forward.
Smart Tissue Autonomous Robot (STAR) Market Segment Outlook: Which Categories Are Expanding The Fastest?
The smart tissue autonomous robot (star) market covered in this report is segmented –
1) By Component: Hardware; Software
2) By Surgical Technique: Open Surgery; Minimally Invasive Surgery; Endoscopic Surgery
3) By Technology: Artificial Intelligence; Machine Learning; Computer Vision; Robotic Manipulation
4) By Application: Soft Tissue Surgery; Plastic And Reconstructive Surgery; Orthopedic Surgery; Gastrointestinal Surgery; Cardiothoracic Surgery
5) By End-User: Hospitals; Ambulatory Surgical Centers; Research Institutions; Clinics
Subsegments:
1) By Hardware: Sensors; Actuators; Robotic Arms; Control Units; Imaging Modules; Power Systems
2) By Software: Algorithmic Control Software; Machine Learning Platforms; Surgical Planning Software; Real Time Navigation Software; Image Processing Software; Data Analytics Software
Smart Tissue Autonomous Robot (STAR) Market Key Companies And Competitive Benchmarking
Major companies operating in the smart tissue autonomous robot (star) market are Johnson & Johnson, Medtronic, ABB Ltd, Siemens Healthineers, Stryker Corporation, Philips, Boston Scientific, Zimmer Biomet Holdings, Inc., Intuitive Surgical, Smith & Nephew plc, KARL STORZ, Globus Medical, Inc., Renishaw plc, CMR Surgical Limited, Osso VR, Caresyntax, Think Surgical, Inc, Activ Surgical, Tuodao Medical, Sina Robotics & Medical Innovators Co
Access The Complete Smart Tissue Autonomous Robot (STAR) Market Report:
Smart Tissue Autonomous Robot (STAR) Market Largest Region By Revenue And Market Share
North America was the largest region in the smart tissue autonomous robot (STAR) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart tissue autonomous robot (star) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model